GlassScriptPhysician profile
Dino Maglic
NPI 1639602790
$6,464.70
in general payments reported to CMS, 2019-2025
18 companies · $2,367 in 2025
The $2,367 reported for 2025 was more than what 87% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $780 · 2020: $165 · 2021: $324 · 2022: $599 · 2023: $546 · 2024: $1,684 · 2025: $2,367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,927 · Travel and Lodging: $1,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,926.87 |
| Travel and Lodging | $1,670.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,202.52 | 2024-2025 | |
| Motiva USA, LLC | $1,246.62 | 2024-2025 | |
| Mentor Worldwide LLC | $670.32 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Solta Medical, A Division of Bausch Health US, LLC | $398.44 | 2019-2025 | |
| Ethicon US, LLC | $373.22 | 2021-2023 | Dermabond |
| Depuy Synthes Sales INC. | $287.27 | 2019-2020 | |
| Allergan, INC. | $281.68 | 2019-2022 | |
| Tela Bio, INC. | $188.13 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Stryker Corporation | $187.17 | 2019-2023 | Variax |
| Bard Peripheral Vascular, INC. | $144.50 | 2021 | |
| Acell, INC. | $128.50 | 2019 | |
| Coopersurgical, INC. | $113.63 | 2020 | |
| Integra Lifesciences Corporation | $64.26 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Sientra, INC. | $59.23 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $56.86 | 2024-2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $31.09 | 2024-2025 | Prevena |
| Musculoskeletal Transplant Foundation INC. | $17.72 | 2025 | |
| Kci USA, INC. | $13.54 | 2023 | Prevena Restor Bellaform, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dino Maglic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.